OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Singapore, the United States, Spain, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of pre-clinical and clinical development and commercial supply of biologics.
OneSource Specialty Pharma Limited (ONESOURCE) is listed on the NSE in the Healthcare sector, Biotechnology industry. The ONESOURCE share price is ₹1,599.80 (+1.32% today), with a market capitalisation of ₹183B. MarketRipple tracks the ONESOURCE investment thesis, the ripple-chain impact of market events on OneSource Specialty Pharma Limited, and the Healthcare sector outlook.
Open
₹1,581.90
High
₹1,619.10
Low
₹1,566.00
Prev. Close
₹1,579.00
52W High
₹1,917.80
52W Low
₹1,057.00
Day range
₹1,566.00–₹1,619.10
52-week range
₹1,057.00–₹1,917.80
Volume
276K
P/E
—
ROE
-0.0%
D/E
0.26
Margin
-0.1%
OneSource Specialty Pharma Limited (NSE: ONESOURCE) is currently trading at ₹1,599.80 (+1.32%).
OneSource Specialty Pharma Limited's market capitalization is ₹183B.
OneSource Specialty Pharma Limited operates in the Healthcare sector (Biotechnology).
Analyst consensus on OneSource Specialty Pharma Limited currently reads strongly positive, based on 4 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.